Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation

Atrial fibrillation (AF) is the most common sustained arrhythmia associated with several cardiac risk factors, but increasing evidences indicated a genetic component. Indeed, genetic variations of the specific PITX2 gene have been identified in patients with early-onset AF. To investigate the molecu...

Full description

Bibliographic Details
Main Authors: Cristina Mora, Marialaura Serzanti, Alessio Giacomelli, Silvia Beltramone, Eleonora Marchina, Valeria Bertini, Giovanna Piovani, Lena Refsgaard, Morten Salling Olesen, Venusia Cortellini, Patrizia Dell'Era
Format: Article
Language:English
Published: Elsevier 2017-10-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506117301642
id doaj-bb39b3bfa901468e8107d6a5fb2e1906
record_format Article
spelling doaj-bb39b3bfa901468e8107d6a5fb2e19062020-11-25T01:09:25ZengElsevierStem Cell Research1873-50611876-77532017-10-0124C81110.1016/j.scr.2017.08.007Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutationCristina Mora0Marialaura Serzanti1Alessio Giacomelli2Silvia Beltramone3Eleonora Marchina4Valeria Bertini5Giovanna Piovani6Lena Refsgaard7Morten Salling Olesen8Venusia Cortellini9Patrizia Dell'Era10Cellular Fate Reprogramming Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyCellular Fate Reprogramming Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyCellular Fate Reprogramming Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyThe Heart Centre, Rigshospitalet, Laboratory for Molecular Cardiology, Copenhagen, DenmarkThe Heart Centre, Rigshospitalet, Laboratory for Molecular Cardiology, Copenhagen, DenmarkDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, Forensic Medicine Unit, University of Brescia, Brescia, ItalyCellular Fate Reprogramming Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyAtrial fibrillation (AF) is the most common sustained arrhythmia associated with several cardiac risk factors, but increasing evidences indicated a genetic component. Indeed, genetic variations of the specific PITX2 gene have been identified in patients with early-onset AF. To investigate the molecular mechanisms underlying AF, we reprogrammed to pluripotency polymorphonucleated leukocytes isolated from the blood of a patient carrying a PITX2 p.M200V mutation, using a commercially available non-integrating expression system. The generated iPSCs expressed pluripotency markers and differentiated toward cells belonging to the three embryonic germ layers. Moreover, the cells showed a normal karyotype and retained the PITX2 p.M200V mutation.http://www.sciencedirect.com/science/article/pii/S1873506117301642
collection DOAJ
language English
format Article
sources DOAJ
author Cristina Mora
Marialaura Serzanti
Alessio Giacomelli
Silvia Beltramone
Eleonora Marchina
Valeria Bertini
Giovanna Piovani
Lena Refsgaard
Morten Salling Olesen
Venusia Cortellini
Patrizia Dell'Era
spellingShingle Cristina Mora
Marialaura Serzanti
Alessio Giacomelli
Silvia Beltramone
Eleonora Marchina
Valeria Bertini
Giovanna Piovani
Lena Refsgaard
Morten Salling Olesen
Venusia Cortellini
Patrizia Dell'Era
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation
Stem Cell Research
author_facet Cristina Mora
Marialaura Serzanti
Alessio Giacomelli
Silvia Beltramone
Eleonora Marchina
Valeria Bertini
Giovanna Piovani
Lena Refsgaard
Morten Salling Olesen
Venusia Cortellini
Patrizia Dell'Era
author_sort Cristina Mora
title Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation
title_short Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation
title_full Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation
title_fullStr Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation
title_full_unstemmed Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation
title_sort generation of induced pluripotent stem cells (ipsc) from an atrial fibrillation patient carrying a pitx2 p.m200v mutation
publisher Elsevier
series Stem Cell Research
issn 1873-5061
1876-7753
publishDate 2017-10-01
description Atrial fibrillation (AF) is the most common sustained arrhythmia associated with several cardiac risk factors, but increasing evidences indicated a genetic component. Indeed, genetic variations of the specific PITX2 gene have been identified in patients with early-onset AF. To investigate the molecular mechanisms underlying AF, we reprogrammed to pluripotency polymorphonucleated leukocytes isolated from the blood of a patient carrying a PITX2 p.M200V mutation, using a commercially available non-integrating expression system. The generated iPSCs expressed pluripotency markers and differentiated toward cells belonging to the three embryonic germ layers. Moreover, the cells showed a normal karyotype and retained the PITX2 p.M200V mutation.
url http://www.sciencedirect.com/science/article/pii/S1873506117301642
work_keys_str_mv AT cristinamora generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT marialauraserzanti generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT alessiogiacomelli generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT silviabeltramone generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT eleonoramarchina generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT valeriabertini generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT giovannapiovani generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT lenarefsgaard generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT mortensallingolesen generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT venusiacortellini generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
AT patriziadellera generationofinducedpluripotentstemcellsipscfromanatrialfibrillationpatientcarryingapitx2pm200vmutation
_version_ 1725178954317299712